Increased mortality and morbidity risk in people with early HIV care interruption in Spain
Rebeca Izquierdo, Félix Gutiérrez(Universitat de Miguel Hernández d'Elx), Rafael Rubio(Research Institute Hospital 12 de Octubre), Inmaculada Jarrín(Instituto de Salud Carlos III), Sergio Reus(Instituto de Salud Carlos III), Arkaitz Imaz(Bellvitge University Hospital), Marta Rava(Instituto de Salud Carlos III), César Sotomayor(Instituto de Biomedicina de Sevilla), Lucio García‐Fraile(Instituto de Salud Carlos III), Melchor Riera(Instituto de Salud Carlos III), José Antonio Iribarren(Biogipuzkoa Health Research Institute)
Cited by 3
Related Papers
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342